abstract |
The present invention is concerned with novel sulfonamides of formula I n nwherein R 1 , R 2 , Ar, Hetaryl, m and n are as described in the description and claims. The compounds are orexin receptor antagonists, useful in the treatment of disorders, in which orexin pathways are involved. |